Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has reported a net operating cash outflow of US$77.8 million for the year ended December 31, 2025, as it increased spending across clinical, regulatory and manufacturing work to support its global pivotal PARADIGM trial.
The structural heart company said research and development expenses totalled US$69.1 million in 2025, reflecting manufacturing and quality scale-up work, higher R&D headcount, PARADIGM preparatory activities and clinical costs linked to enrolling additional patients, alongside expansion of its field-based clinical team and medical affairs activities.
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) will present updated clinical data on its lead cell therapy program at one of the world’s largest healthcare investment forums next week, as the company continues to build international visibility around its immuno-oncology pipeline.
The clinical-stage biotech said chief medical officer Dr John Byon will present at the TD Cowen 46th Annual Health Care Conference in Boston at 1:10 pm ET on Monday, March 2, 2026.
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has reported revenue of US$6.12 million for the six months to December 31, 2025 (1H FY26), down slightly from US$6.31 million a year earlier, as the company progressed multiple FebriDx commercial and regulatory milestones in the US.
Product sales rose, led by FebriDx, with sale of goods increasing to US$1.68 million from US$0.84 million in 1H FY25. Lumos said the uplift reflected an additional US$1.39 million in FebriDx revenue, more than offsetting the absence of US$0.65 million in discontinued ViraDx sales recorded in the prior period.
New Era Energy & Digital (NASDAQ:NUAI) said on Thursday it has entered into a non-binding letter of intent to acquire about 54 acres of land adjacent to its Texas Critical Data Centers campus in Ector County, Texas, as it advances lease talks with a hyperscale tenant.
The company, which develops and operates digital infrastructure and integrated power assets in the Permian Basin, said the contemplated acquisition forms part of ongoing negotiations with a leading hyperscale tenant and its partners, where securing the additional acreage emerged as a key milestone.
Lion Copper and Gold Corp (TSX-V:LEO, OTCQB:LCGMF, FRA:QR20) is right where a junior mining company wants to be in the metals market of early 2026, with its brownfield Yerington Copper Project, situated in the famously mining-friendly jurisdiction of Nevada, set for both further exploration and a push for production before the decade is out.
Adding to the company’s strengths is that Yerington aligns well with the growing U.S. demand for domestically supplied critical minerals.
Celsius Holdings (NASDAQ:CELH) shares surged nearly 9% after the company reported fourth-quarter 2025 results that exceeded Wall Street expectations on both revenue and earnings.
For the three months ended December 31, 2025, Celsius posted revenue of approximately $721.6 million, above analysts’ forecast of $640.8 million.
Gunnison Copper Corp (TSX:GCU, OTCQB:GCUMF, FRA:3XS0) has reported improved economics in an updated Preliminary Economic Assessment (PEA) for its wholly owned Gunnison Copper Project in Cochise County, Arizona, replacing the prior study released in December 2024.
The company said the 2026 assessment reflects stronger project value driven by higher copper price assumptions and operational enhancements.
Ideal Power Inc (NASDAQ:IPWR, FRA:5ILA) announced that it has closed its previously announced underwritten public offering and concurrent private placement, raising about $14 million in gross proceeds to support its commercialization efforts.
The Austin, Texas-based company issued about 4.5 million shares of common stock, or pre-funded warrants in lieu thereof, in the public offering. It also completed a private placement of pre-funded warrants to purchase up to roughly 0.6 million additional shares.
Northstar Gold Corp. (CSE:NSG) has announced a non-brokered private placement to partially fund permitting, engineering, and the initial implementation of Novamera’s Surgical Mining system at its 100%-owned Cam Copper Project in Ontario.
The financing will provide capital for Northstar’s Cam Copper Zone 2 Surgical Mining pilot, being advanced under a Turnkey Surgical Mining Services Agreement executed with Novamera in October 2025.
Pinnacle Silver & Gold Corp (TSX-V:PINN, OTCQB:PSGCF, FRA:P9J) said it has made substantial progress at its high-grade El Potrero Project in Durango, Mexico, moving closer to a production decision by the end of 2026.
The company, which has been advancing the project for a year, said it is set to begin rehabilitation of historic mine workings along the main Dos de Mayo vein trend. Underground delineation drilling will follow, with surface drilling planned once a pending environmental permit is approved.
AtaiBeckley NV (NASDAQ:ATAI, XETRA:9VC) reported positive topline results from an exploratory Phase 2a trial evaluating its oral R-MDMA candidate, EMP-01, in adults with social anxiety disorder (SAD), with the study meeting its primary safety objective and showing encouraging efficacy signals.
The clinical-stage biotechnology company said the randomized, double-blind, placebo-controlled study enrolled 71 adults with moderate-to-severe SAD across seven sites in the United Kingdom. Participants received two in-clinic administrations of EMP-01 (225 mg) or placebo spaced 28 days apart, without adjunctive psychotherapy.
C3 Metals Inc (TSX-V:CCCM, OTC:CUAUF) said it has intersected copper mineralization in all 12 drill holes completed to date at its wholly owned Khaleesi project in southern Peru, as the junior explorer ramps up drilling at the greenfield prospect.
The company has drilled 6,300 metres across a 1,000-by-500 metre footprint at the Khaleesi copper project, marking the first-ever drill campaign on the property.
Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF, FRA:1SS) announced that it has added new Tier 1 and Tier 2 enterprise clients, expanding adoption of its AI Events Operating System (EOS) as demand for automated event infrastructure grows.
The company said the new customer wins reflect continued enterprise uptake of its unified platform, which combines Krafty Lab, Eventdex and Map D to support in-person, hybrid and virtual events. EOS automates functions such as registration, on-site operations, analytics and attendee engagement.
Immunic Inc (NASDAQ:IMUX) said it is entering a pivotal period for its multiple sclerosis program after securing up to $400 million in new financing and advancing its lead drug into late-stage development, with key data expected by the end of 2026.
The biotechnology company’s oral candidate, vidofludimus calcium (IMU-838), is currently being evaluated in the twin phase 3 ENSURE-1 and ENSURE-2 trials in relapsing multiple sclerosis (RMS).
Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF, FRA:A6Y0) said its proved reserves jumped 79% at the end of 2025, driven by drilling success in Brazil and the addition of Canadian assets, as the company also outlined its 2026 capital plan.
The Calgary-based oil and gas producer reported total proved (1P) reserves of 8.1 million barrels of oil equivalent (MMboe) at the end of December 2025. Proved plus probable (2P) reserves rose 43% to 13.1 MMboe, according to an independent evaluation.
The AIM-listed immunotherapy specialist will present three posters at the AAAAI Annual Meeting in Philadelphia this week
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed biotechnology company specialising in allergy treatments, said it would present positive clinical and safety data from across its research portfolio at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Philadelphia.
The AIM-listed neuroscience analytics company presented data showing its automated platform could replace labour-intensive manual methods in clinical trials
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the London-listed neuroscience imaging company, has published data showing that its artificial intelligence-driven platform can measure brain shrinkage at least as accurately as methods requiring analysis by human experts.
EcoGraf Ltd (ASX:EGR, OTCQX:ECGFF) has completed an updated bankable feasibility study (BFS) for its Epanko Graphite Project in Tanzania, outlining a 73,000-tonne-per-annum (tpa) operation with a pre-tax net present value (NPV10) of US$516 million and an internal rate of return of 31.1%.
The revised study increases planned throughput by 21.7% to 73,000 tpa for the first 15 years, supported by an updated ore reserve of 16.7 million tonnes at 8.2% total graphite carbon. Pre-production capital is estimated at US$181.2 million, with additional resettlement costs of US$18.1 million. Annual EBITDA is projected at US$85.7 million, based on a life-of-mine basket price of US$1,746 per tonne.
Novo Resources Corp (TSX:NVO, OTCQX:NSRPF, ASX:NVO, FRA:1NOR) has secured firm commitments to raise about A$8.2 million, exceeding the A$6 million initially targeted earlier this week, as the gold explorer moves to accelerate drilling across its Western Australian and Victorian projects.
The company said it had received commitments for C$7.9 million (about A$8.2 million) through a placement of around 16.8 million units at C$0.10 per unit and about 61.1 million CHESS Depository Interests (CDIs) at A$0.105 per CDI to institutional, professional and sophisticated investors.